Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation

Estimated Value: $750,000
Closing Soon 7 days left MarylandHealthcaresolicitation
Aug 26, 2026
Sep 10, 2026 7:00 PM
Healthcare
solicitation
541714
AI Summary
This bid is for a preclinical research project to assess the effectiveness of naloxone in reversing respiratory depression caused by polysubstance use, specifically requiring in vivo validation studies.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation 1 project $750,000.00 $750,000.00 Professional Services
Estimated Bid Value$750,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Bids in MarylandHealthcare BidsSOLICITATION BidsClosing Soon All Bids